Skip to main content
Novartis
language-selector-globe Italia | it
Siti Novartis
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Italia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Chi siamo 
      • Novartis in Italia 
      • La nostra missione 
      • Aree di attività 
        • Aree terapeutiche 
      • Diversity & Inclusion 
      • La nostra storia 
        • Le nostre origini 
        • Dal 1996 a oggi 
      • Persone 
      viale affollato Chi siamo
    • Per il paziente 
      • Il nostro impegno 
      • Alleati per la Salute 
        • Politiche Sanitarie e Socio Assistenziali 
        • A fianco di chi aiuta 
        • Benessere psicofisico 
        • News dalle Associazioni Pazienti 
        • Mini Lessons EUPATI 
        • Servizi e materiali utili 
        • Novartis Influencer Masterclass for Patients 
        • HTA - Nuovo regolamento 
        • Attualità 
      • Informazione e sensibilizzazione 
        • Campagne di informazione e sensibilizzazione 
      • Linea Embrace per la gestione delle malattie croniche 
      • Segnalazione effetti indesiderati 
      Un medico tiene le mani a un paziente Per il paziente
    • Sostenibilità 
      • Sostenibilità ambientale 
      • Etica e compliance 
      • Diversity & Inclusion 
      • Accesso e diritto alla salute 
      • Salute globale 
      • Reporting 
      • Indici ESG 
      Young patients waiting outside hospital in Rwanda Sostenibilità
    • Ricerca e innovazione 
      • Ricerca & sviluppo 
      • Nuove frontiere della R&S 
      • Novartis, la ricerca clinica in Italia nel 2023 
      • Open Innovation 
      • Professionisti della salute 
      dettaglio di una confezione di pillole Ricerca e innovazione
    • Lavora con noi 
      • Opportunità di lavoro 
      • Come lavoriamo 
      • Benessere 
      • Benefit 
      • Diversity & Inclusion 
      • Riconoscimenti e certificazioni 
      • La nostra cultura 
      Lavora con noi Lavora con noi
    • News 
      • Fatti e notizie 
      • Area riservata ai giornalisti 
      • Comunicati stampa 
      News News
    • Contatti 
    Homepage Italia Home
  1. Home
  2. Lavora con noi
  3. Cerca offerte di lavoro
  • Sort by Sort ascending
  • Titolo di lavoro
  • Site
  • Posizione
  • Divisione
  • Business
  • Area funzionale Sort descending
  • Data di pubblicazione
Titolo di lavoro Site Posizione Divisione Business Area funzionale Sort descending Data di pubblicazione
Analyst Stratégique H/F) en Stage Rueil-Malmaison Francia International Innovative Medicines Others Ago 19, 2024
Lehrling Chemieverfahrenstechnik Schaftenau Austria Operations Innovative Medicines Others Set 12, 2024
Juristisches Volontariat – Novartis Corporate Functions Basel (City) Svizzera Legal Corporate Others Set 26, 2024
Werkstudent (w/m/d) im Bereich Medical Statistics / Epidemiology / Health Statistics Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germania International Innovative Medicines Others Set 30, 2024
Legal Trainee / Rechtsreferendar (m/f/d) in der Rechtsanwaltsstation oder im Pflichtwahlpraktikum Munich (Novartis Business Services GmbH) Germania Legal CTS Others Ott 04, 2024
Pharmaziepraktikant (w/m/d) im Quality Management ab Mai 2025 Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germania Operations Innovative Medicines Others Ott 09, 2024
Duales Studium (Bachelor) BWL Industrie Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germania People & Organization Innovative Medicines Others Ott 10, 2024
Duales Studium (Bachelor) BWL Gesundheitsmanagement Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germania People & Organization Innovative Medicines Others Ott 10, 2024
QA Compliance Postgraduate Stein Aargau Svizzera Operations Innovative Medicines Others Ott 14, 2024
Postgraduate Program in TRD-Biologics Basel (City) Svizzera Development Innovative Medicines Others Ott 15, 2024
Legal Trainee - Legal Procurement, Data/Digital & IT Basel (City) Svizzera Legal CTS Others Ott 10, 2024
Postdoc Patient-Centered Outcomes Basel (City) Svizzera Development Innovative Medicines Others Ott 09, 2024
Supply Chain Graduate Program Associate - UAE National Dubai Emirati Arabi Uniti Operations Innovative Medicines Others Ott 14, 2024
Lehrling Elektrotechnik Schaftenau Austria Operations Innovative Medicines Others Set 11, 2024
Lehre Labortechnik Schaftenau Austria Operations Innovative Medicines Others Set 11, 2024
Lehrling Mechatronik Schaftenau Austria Operations Innovative Medicines Others Set 11, 2024
Long term Finance Internship İstanbul Kavacık Turchia Finance Innovative Medicines Others Set 10, 2024
Chef de Projet Omnicanal – Apprenti H/F Paris Headquarter (Novartis Pharma S.A.S.) Francia International Innovative Medicines Others Lug 04, 2024
Alternant MARKET ACCES Paris Headquarter (Novartis Pharma S.A.S.) Francia International Innovative Medicines Others Mag 16, 2024
Alternant MARKET ACCES Paris Headquarter (Novartis Pharma S.A.S.) Francia International Innovative Medicines Others Mag 16, 2024
Alternant MARKET ACCES Paris Headquarter (Novartis Pharma S.A.S.) Francia International Innovative Medicines Others Mag 16, 2024
Alternant CONTRÔLE DE GESTION - BPA Paris Headquarter (Novartis Pharma S.A.S.) Francia Finance Innovative Medicines Others Mag 17, 2024
ALTERNANT Expert en développement des compétences Paris Headquarter (Novartis Pharma S.A.S.) Francia Innovative Medicines Others Mag 21, 2024
Alternant INGENIEUR DATA Paris Headquarter (Novartis Pharma S.A.S.) Francia International Innovative Medicines Others Mag 23, 2024
Alternant CHEF DE PROJET (Maladie de Verneuil/Urticaire Chronique) Paris Headquarter (Novartis Pharma S.A.S.) Francia International Innovative Medicines Others Mag 28, 2024
APPRENTI(E) COORDINATEUR FORMATION (H/F) Huningue Francia Operations Innovative Medicines Others Mag 31, 2024
Embrace Advisor Verona Field Force (Italy) Italia International Innovative Medicines Others Ott 16, 2024
IT Strategic Business Partner US&I (Salesforce) Barcelona Gran Vía Spagna Operations CTS Technology Transformation Ott 01, 2024
Sr. Spec. DDIT IES NW Engg Hyderabad (Office) India Operations CTS Technology Transformation Ott 16, 2024
Associate Director, QC IT Solution Delivery Ljubljana Slovenia Operations CTS Technology Transformation Ott 16, 2024
Associate Director QC IT - LIMS Master Data Governance Ljubljana Slovenia Operations CTS Technology Transformation Ott 16, 2024
Director - LDC Business and IT Controls(SAP S/4 Hana) Hyderabad (Office) India Operations CTS Technology Transformation Ott 16, 2024
IT Business Partner Director for Clinical Development Barcelona Gran Vía Spagna Operations CTS Technology Transformation Ott 17, 2024
Sr Principal Observability Engineer Hyderabad (Office) India Biomedical Research Pharma Research Technology Transformation Ott 17, 2024
Sr.Spec.DDIT ISC Gov Indep.Control Asses Hyderabad (Office) India Operations CTS Technology Transformation Set 18, 2024
Sr. Spec. DDIT IES DB & MW Services-IES- Cloud Platform Svcs Hyderabad (Office) India Operations CTS Technology Transformation Set 19, 2024
Container Solutions Senior Engineer INSURGENTES Messico Operations CTS Technology Transformation Set 19, 2024
Assoc. Dir. DDIT ISC Gov SOX IT Testing Hyderabad (Office) India Operations CTS Technology Transformation Set 20, 2024
Sr. Spec. DDIT ISC Gov SOX IT Method Hyderabad (Office) India Operations CTS Technology Transformation Set 20, 2024
Associate Director, IT Project Manager, M&A Prague Repubblica Ceca Operations CTS Technology Transformation Set 23, 2024
Associate Director, SUSE Linux Administrator Prague Repubblica Ceca Operations Corporate Technology Transformation Set 23, 2024
Associate Director - Cloud Security Architect Prague Repubblica Ceca Operations CTS Technology Transformation Lug 23, 2024
LDC IT Planning Manager Prague Repubblica Ceca Operations CTS Technology Transformation Set 03, 2024
Project Manager Selangor Malaysia Operations CTS Technology Transformation Set 03, 2024
Višji specialist proizvodno informacijskih sistemov / Senior Specialist IT MES Ljubljana Slovenia Operations CTS Technology Transformation Set 03, 2024
Senior Specialist IT (Service Operations Expert) Prague Repubblica Ceca Operations CTS Technology Transformation Set 03, 2024
Assoc. Dir. DDIT Dev. GCO Tech. Design (Technical Business Analyst) Hyderabad (Office) India Operations CTS Technology Transformation Ago 05, 2024
Sr. Spec. Cloud Infrastructure Solution Delivery - Global Drug Development INSURGENTES Messico Operations CTS Technology Transformation Set 03, 2024
Senior Specialist DDIT ISC Detection & Response Hyderabad (Office) India Operations CTS Technology Transformation Ott 17, 2024
Sr. Specialist DDIT ISC Detection & Response Hyderabad (Office) India Operations CTS Technology Transformation Ott 17, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • › Next page

Novartis Farma S.p.A Viale Luigi Sturzo, 43 - 20154 Milano (MI) tel. 02/9654.1
C.F. 07195130153 / P.IVA 02385200122

Novartis Italia

Naviga
  • Per il paziente
  • Professionisti della salute
  • Sostenibilità
  • News
  • Lavora con noi
  • Novartis nel mondo
News
  • Archivio news
  • Fatti & Notizie
  • Comunicati Stampa
  • Area riservata ai giornalisti
Siti web Novartis
  • Sito del gruppo
Footer Bottom
© 2024 Novartis Italia
  • Avvertenze legali
  • Privacy Policy
  • Contatti
  • Impostazioni cookie
  • Mappa del sito
  • Accessibilità
Elenco siti Novartis
Questo sito è destinato a utenti residenti in Italia